Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

In addition to apartments and townhomes, the project will feature a restaurant and cocktail lounge, a dog park and a ...

Taylor Swift's legal team filed the final trademark registration extension for "Reputation (Taylor's Version)" and "Taylor ...

As we warned in December 2023, multiple trademark owners have contacted Blank Rome to say that, in a renewed fraud, scam ...

How President Trump's recent return-to-office executive order has sparked a wave of concern among USPTO staff.

Kristina Caggiano Kelly, David H. Holman and Lestin L. Kenton Jr. of Sterne, Kessler, Goldstein & Fox PLLC discuss a Federal ...

Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the grant of a new U.S. patent by ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

Duos Technologies has secured a new patent for its railcar undercarriage inspection technology, obliquevue, from the US ...